logo

MAZE

Maze Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-01
5.58 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Trend Analysis of MAZE
  • Based on a composite score of 5.58/10, we rate MAZE as a Netural. Our analysis breaks down into 4.25/10 for Fundamentals, 2.12/10 for Technicals, and 7.97/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is MAZE undervalued or overvalued?
Technical Analysis of MAZE?
Is money flowing into or out of MAZE?